154 results on '"Gad, Hans-Henrik"'
Search Results
2. PD-L1 and PD-L2 immune checkpoint protein induction by type III interferon in non-small cell lung cancer cells
3. Establishment of well-differentiated camelid airway cultures to study Middle East respiratory syndrome coronavirus
4. Two cGAS-like receptors induce antiviral immunity in Drosophila
5. Defective interferon priming and impaired antiviral responses in a patient with an IRF7 variant and severe influenza
6. Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin
7. Cryo‐EM structure of the human NKCC1 transporter reveals mechanisms of ion coupling and specificity
8. IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
9. Cryo-EM structure of the human NKCC1 transporter reveals mechanisms of ion coupling and specificity
10. Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice
11. Chikungunya Virus Envelope Protein E2 Provides a Vector for Targeted Antigen Delivery to Human Dermal CD14+ Dendritic Cells
12. Cryo-EM structure of the human NKCC1 transporter reveals mechanisms of ion coupling and specificity
13. Interferon-λ Improves the Efficacy of Intranasally or Rectally Administered Influenza Subunit Vaccines by a Thymic Stromal Lymphopoietin-Dependent Mechanism
14. Comparing the stability and activity of recombinant IFNλ3 and IFNλ4: ID: 191
15. Investigating the role of interferon λ4 in hepatitis C virus infection: ID: 101
16. Selective Janus kinase inhibition preserves interferon-λ–mediated antiviral responses
17. 2′3′-cGAMP triggers a STING- and NF-κB–dependent broad antiviral response in Drosophila
18. A novel role for the oligoadenylate synthetase-like protein in viral recognition and interferon induction: 85
19. Mapping the active site and investigating the polyI:C inducibility of the human 120 kDa 2’-5’ Oligoadenylate Synthetase 3: PS2-008
20. Inhibition of SARS–CoV-2 by type I and type III interferons
21. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
22. Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation
23. The IFNL4 Gene Is a Noncanonical Interferon Gene with a Unique but Evolutionarily Conserved Regulation
24. Length dependent activation of OAS proteins by dsRNA
25. The battle between host and virus: how chikungunya virus is inhibited by 2′-5′-oligoadenylate synthetases and how it may escape the battle: SS10-7
26. Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines
27. 220 Antiviral potency of interferon lambda and identification of amino acids that are important for the antiviral activity of interferon Lambda II
28. 2’3’-cGAMP triggers a STING and NF-κB dependent broad antiviral response in Drosophila
29. Identification of an IRF3 variant and defective antiviral interferon responses in a patient with severe influenza
30. The Influence of the rs30461 Single Nucleotide Polymorphism on IFN-λ1 Activity and Secretion
31. Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ
32. IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission
33. Author response: IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission
34. The interferon-stimulated gene product oligoadenylate synthetase-like protein enhances replication of Kaposi’s sarcoma-associated herpesvirus (KSHV) and interacts with the KSHV ORF20 protein
35. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses
36. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses
37. IFN λ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFN α treatment
38. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses
39. ID: 101
40. ID: 191
41. Functional IRF3 deficiency in a patient with herpes simplex encephalitis
42. Rapid Uptake and Inhibition of Viral Propagation by Extracellular OAS1
43. Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling
44. Selection of a novel and highly specific tumor necrosis factor alpha (TNFalpha) antagonist:insight from the crystal structure of the antagonist-TNFalpha complex
45. The 2′-5′-Oligoadenylate Synthetase 3 Enzyme Potently Synthesizes the 2′-5′-Oligoadenylates Required for RNase L Activation
46. 85
47. Mapping of Chikungunya Virus Interactions with Host Proteins Identified nsP2 as a Highly Connected Viral Component
48. PS2-008. Mapping the active site and investigating the polyI:C inducibility of the human 120 kDa 2’-5’ Oligoadenylate Synthetase 3
49. The Oligoadenylate Synthetase Family: An Ancient Protein Family with Multiple Antiviral Activities
50. SS10-7 The battle between host and virus: how chikungunya virus is inhibited by 2′-5′-oligoadenylate synthetases and how it may escape the battle
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.